Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Retracted of European Journal of Gynaecological Oncology. 2025. 46(5)
Retraction: Diagnostic value of transvaginal ultrasound combined with serum CA125 and HE4 in differentiating benign and malignant ovarian tumors
1MRE Press No. 50 Tagore Lane, 03-01 (H), 787494 Singapore, Singapore
*Corresponding Author(s): European Journal of Gynaecological Oncology Editorial Office E-mail: editor@ejgo.net
Post-publication, an investigation initiated by editorial team identified that a large proportion of the references cited in the article [1] have low relevance or no direct connection to the study’s methods, results, or discussion. This extensive use of irrelevant citations undermines the academic rigor and reliability of the published work. The article is therefore retracted. The authors did not respond with the retraction.
The journal apologizes to its readers for any inconvenience caused.
European Journal of Gynaecological Oncology Editorial Office. Retraction: Diagnostic value of transvaginal ultrasound combined with serum CA125 and HE4 in differentiating benign and malignant ovarian tumors. European Journal of Gynaecological Oncology. 2026. 47(2);60-60.
[1] Liu XX, Han Y. Diagnostic value of transvaginal ultrasound combined with serum CA125 and HE4 in differentiating benign and malignant ovarian tumors. European Journal of Gynaecological Oncology. 2025; 46: 130–137.
Top